{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Oxatomide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Oxatomide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Oxatomide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "oxatomide",
    "trial_2_text": "Oxatomide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Oxatomide Supplement: 60 participants will take Oxatomide 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Oxatomide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Oxatomide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.17823396623134613,
      "87": 0.16350997984409332,
      "9": 0.14315693080425262,
      "177": 0.14110469818115234,
      "46": 0.13602930307388306,
      "173": 0.1347951889038086,
      "17": 0.13074254989624023,
      "77": 0.12769809365272522,
      "68": 0.1241598054766655,
      "21": 0.11930252611637115,
      "37": 0.11747390031814575,
      "49": 0.11733203381299973,
      "79": 0.1173006147146225,
      "123": 0.11619337648153305,
      "20": 0.11163794994354248,
      "189": 0.10761657357215881,
      "200": 0.1039205864071846,
      "188": 0.09684208780527115,
      "14": 0.09399659186601639,
      "67": 0.09228912740945816,
      "228": 0.09197086095809937,
      "114": 0.09005582332611084,
      "243": 0.0839279368519783,
      "102": 0.08190232515335083,
      "126": 0.08062811195850372,
      "101": 0.07862251996994019,
      "239": 0.0782179906964302,
      "116": 0.07448993623256683,
      "104": 0.07417996227741241,
      "350": 0.07177168130874634,
      "85": 0.06993693858385086,
      "5": 0.06973325461149216,
      "64": 0.0649852603673935,
      "76": 0.06371243298053741,
      "86": 0.06361003965139389,
      "69": 0.06307827681303024,
      "466": 0.062416382133960724,
      "180": 0.06183376535773277,
      "29": 0.06104006990790367,
      "131": 0.05997781082987785,
      "262": 0.05890513211488724,
      "2": 0.05889207497239113,
      "139": 0.05821846425533295,
      "193": 0.0574716180562973,
      "61": 0.05681712180376053,
      "38": 0.05433017760515213,
      "30": 0.054225318133831024,
      "92": 0.05415142700076103,
      "72": 0.053776588290929794,
      "151": 0.053693316876888275,
      "179": 0.05196542292833328,
      "27": 0.05075792968273163,
      "28": 0.05023278668522835,
      "454": 0.049998294562101364,
      "204": 0.04749477654695511,
      "18": 0.046900320798158646,
      "153": 0.04686233401298523,
      "341": 0.04673488810658455,
      "355": 0.046411991119384766,
      "508": 0.045569051057100296,
      "456": 0.045390188694000244,
      "194": 0.04503312334418297,
      "261": 0.04470663517713547,
      "97": 0.0444774329662323,
      "82": 0.04438692331314087,
      "396": 0.04420521482825279,
      "122": 0.044119611382484436,
      "282": 0.04314708709716797,
      "147": 0.042989231646060944,
      "66": 0.04297717660665512,
      "276": 0.04226129129528999,
      "164": 0.04178566858172417,
      "441": 0.041645899415016174,
      "286": 0.0414486862719059,
      "132": 0.04140818119049072,
      "166": 0.041064970195293427,
      "256": 0.04099208861589432,
      "211": 0.04067643731832504,
      "36": 0.04056301340460777,
      "199": 0.03997750207781792,
      "96": 0.039506614208221436,
      "422": 0.03933544084429741,
      "253": 0.03827648237347603,
      "269": 0.03824346512556076,
      "75": 0.03803076595067978,
      "98": 0.037831343710422516,
      "186": 0.03699886053800583,
      "208": 0.03686115890741348,
      "35": 0.036502987146377563,
      "152": 0.03630811348557472,
      "11": 0.036127302795648575,
      "212": 0.035840220749378204,
      "451": 0.035788435488939285,
      "394": 0.0355057567358017,
      "371": 0.034716859459877014,
      "382": 0.03458871692419052,
      "457": 0.03395545110106468,
      "242": 0.0335770845413208,
      "221": 0.033476993441581726,
      "297": 0.033349521458148956
    },
    "trial_2_ae": {
      "78": 0.17823396623134613,
      "87": 0.16350997984409332,
      "9": 0.14315693080425262,
      "177": 0.14110469818115234,
      "46": 0.13602930307388306,
      "173": 0.1347951889038086,
      "17": 0.13074254989624023,
      "77": 0.12769809365272522,
      "68": 0.1241598054766655,
      "21": 0.11930252611637115,
      "37": 0.11747390031814575,
      "49": 0.11733203381299973,
      "79": 0.1173006147146225,
      "123": 0.11619337648153305,
      "20": 0.11163794994354248,
      "189": 0.10761657357215881,
      "200": 0.1039205864071846,
      "188": 0.09684208780527115,
      "14": 0.09399659186601639,
      "67": 0.09228912740945816,
      "228": 0.09197086095809937,
      "114": 0.09005582332611084,
      "243": 0.0839279368519783,
      "102": 0.08190232515335083,
      "126": 0.08062811195850372,
      "101": 0.07862251996994019,
      "239": 0.0782179906964302,
      "116": 0.07448993623256683,
      "104": 0.07417996227741241,
      "350": 0.07177168130874634,
      "85": 0.06993693858385086,
      "5": 0.06973325461149216,
      "64": 0.0649852603673935,
      "76": 0.06371243298053741,
      "86": 0.06361003965139389,
      "69": 0.06307827681303024,
      "466": 0.062416382133960724,
      "180": 0.06183376535773277,
      "29": 0.06104006990790367,
      "131": 0.05997781082987785,
      "262": 0.05890513211488724,
      "2": 0.05889207497239113,
      "139": 0.05821846425533295,
      "193": 0.0574716180562973,
      "61": 0.05681712180376053,
      "38": 0.05433017760515213,
      "30": 0.054225318133831024,
      "92": 0.05415142700076103,
      "72": 0.053776588290929794,
      "151": 0.053693316876888275,
      "179": 0.05196542292833328,
      "27": 0.05075792968273163,
      "28": 0.05023278668522835,
      "454": 0.049998294562101364,
      "204": 0.04749477654695511,
      "18": 0.046900320798158646,
      "153": 0.04686233401298523,
      "341": 0.04673488810658455,
      "355": 0.046411991119384766,
      "508": 0.045569051057100296,
      "456": 0.045390188694000244,
      "194": 0.04503312334418297,
      "261": 0.04470663517713547,
      "97": 0.0444774329662323,
      "82": 0.04438692331314087,
      "396": 0.04420521482825279,
      "122": 0.044119611382484436,
      "282": 0.04314708709716797,
      "147": 0.042989231646060944,
      "66": 0.04297717660665512,
      "276": 0.04226129129528999,
      "164": 0.04178566858172417,
      "441": 0.041645899415016174,
      "286": 0.0414486862719059,
      "132": 0.04140818119049072,
      "166": 0.041064970195293427,
      "256": 0.04099208861589432,
      "211": 0.04067643731832504,
      "36": 0.04056301340460777,
      "199": 0.03997750207781792,
      "96": 0.039506614208221436,
      "422": 0.03933544084429741,
      "253": 0.03827648237347603,
      "269": 0.03824346512556076,
      "75": 0.03803076595067978,
      "98": 0.037831343710422516,
      "186": 0.03699886053800583,
      "208": 0.03686115890741348,
      "35": 0.036502987146377563,
      "152": 0.03630811348557472,
      "11": 0.036127302795648575,
      "212": 0.035840220749378204,
      "451": 0.035788435488939285,
      "394": 0.0355057567358017,
      "371": 0.034716859459877014,
      "382": 0.03458871692419052,
      "457": 0.03395545110106468,
      "242": 0.0335770845413208,
      "221": 0.033476993441581726,
      "297": 0.033349521458148956
    }
  },
  "safety": {
    "trial_1_safety": 0.2637813091278076,
    "trial_2_safety": 0.2637813091278076
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4770795404911041
  }
}